We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
-6.12%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.96B
AUM Growth
-$641M
(-11%)
Cap. Flow
-$193M
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
23.33%
Holding
765
New
46
Increased
242
Reduced
270
Closed
98
Avg Time Held
1.5
years
Top 10 Avg Time Held
0.9
years
Top 20 Avg Time Held
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Manhattan Associates
MANH
|
+$33.6M |
| 2 |
Amazon
AMZN
|
+$32.3M |
| 3 |
CEB
CEB Inc.
CEB
|
+$27.7M |
| 4 |
Gilead Sciences
GILD
|
+$27.3M |
| 5 |
Merck
MRK
|
+$25.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$49.9M |
| 2 |
TWX
Time Warner Inc
TWX
|
+$30.5M |
| 3 |
Stericycle Inc
SRCL
|
+$29.3M |
| 4 |
Macquarie Infrastructure Holdings, LLC
MIC
|
+$25M |
| 5 |
Sunoco
SUN
|
+$21.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.16% |
| 2 | Financials | 16.84% |
| 3 | Consumer Discretionary | 14.26% |
| 4 | Technology | 13.32% |
| 5 | Industrials | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
United Natural Foods
UNFI
$2.91B
| $2.23M | 0.04% |
45,859
+17,799
| +63% | +$914K |
2014 Q4
3 quarters
|
|
177
Televisa
TV
$1.29B
| $2.21M | 0.04% |
85,065
-44,294
| -34% | -$1.42M |
2013 Q4
7 quarters
|
|
178
CHS Inc Class B Preferred Stock
CHSCO
$549M
| $2.2M | 0.04% |
77,805
| – | – |
2013 Q3
8 quarters
|
|
|
TRIB
179
Trinity Biotech
TRIB
$6.45M
| $2.18M | 0.04% |
1,272
+71
| +6% | +$171K |
2013 Q2
9 quarters
|
|
180
Caesarstone
CSTE
$93.4M
| $2.16M | 0.04% |
71,069
-23,567
| -25% | -$1.23M |
2013 Q2
9 quarters
|
|
181
Super Micro Computer
SMCI
$23.1B
| $2.15M | 0.04% |
788,200
-2,850,960
| -78% | -$7.58M |
2014 Q4
3 quarters
|
|
|
ALXN
182
DELISTED
Alexion Pharmaceuticals
ALXN
| $2.14M | 0.04% |
13,691
-462
| -3% | -$84.3K |
2013 Q2
9 quarters
|
|
183
Kimberly-Clark
KMB
$34.6B
| $2.12M | 0.04% |
19,430
-241
| -1% | -$26.6K |
2013 Q2
9 quarters
|
|
184
DELISTED
Ultimate Software Group Inc
ULTI
| $2.12M | 0.04% |
11,829
+6,050
| +105% | +$1.08M |
2013 Q2
9 quarters
|
|
185
WEC Energy
WEC
$34.6B
| $2.1M | 0.04% |
40,305
-741
| -2% | -$36K |
2013 Q2
9 quarters
|
|
186
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$25.6B
| $2.1M | 0.04% |
8,438
+32
| +0.4% | +$8.47K |
2013 Q2
9 quarters
|
|
187
Under Armour
UAA
$2.1B
| $2.1M | 0.04% |
43,308
+9,100
| +27% | +$433K |
2014 Q1
6 quarters
|
|
188
Cisco
CSCO
$433B
| $2.09M | 0.04% |
79,750
+1,199
| +2% | +$32.4K |
2013 Q2
9 quarters
|
|
|
CERN
189
DELISTED
Cerner Corp
CERN
| $2.09M | 0.04% |
34,836
-125,501
| -78% | -$8.2M |
2014 Q1
6 quarters
|
|
190
Chubb
CB
$136B
| $2.03M | 0.04% |
19,597
-1,253
| -6% | -$131K |
2013 Q2
9 quarters
|
|
191
iShares Core S&P 500 ETF
IVV
$889B
| $2.01M | 0.04% |
10,407
+118
| +1% | +$24.1K |
2013 Q2
9 quarters
|
|
192
Caterpillar
CAT
$338B
| $1.98M | 0.04% |
30,285
-1,105
| -4% | -$84.5K |
2013 Q2
9 quarters
|
|
193
Coca-Cola
KO
$396B
| $1.98M | 0.04% |
49,234
+1,255
| +3% | +$50.3K |
2013 Q2
9 quarters
|
|
|
SAQ.CL
194
DELISTED
Saratoga Investment Corp.
SAQ.CL
| $1.96M | 0.04% |
77,225
+2,900
| +4% | +$73.4K |
2013 Q2
9 quarters
|
|
|
CLR
195
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $1.95M | 0.04% |
67,256
-123,742
| -65% | -$4.02M |
2013 Q2
9 quarters
|
|
196
MPLX
MPLX
$57.9B
| $1.93M | 0.04% |
50,580
-22,000
| -30% | -$1.12M |
2014 Q1
6 quarters
|
|
197
Yum! Brands
YUM
$41.2B
| $1.92M | 0.04% |
33,463
+6,208
| +23% | +$376K |
2013 Q2
9 quarters
|
|
198
Vanguard Morningstar Small-Cap ETF
VB
$77.9B
| $1.92M | 0.04% |
17,769
+4,455
| +33% | +$521K |
2014 Q1
6 quarters
|
|
199
Ashford Hospitality Trust Series D
AHT.PRD
$4.18M
| $1.92M | 0.04% |
75,105
+1,200
| +2% | +$30.9K |
2013 Q3
8 quarters
|
|
|
SSW.PRD
200
DELISTED
Seaspan Corporation 7.95% Series D Cumulative Redeemable Perpetual Preferred Shares
SSW.PRD
| $1.91M | 0.04% |
82,795
+3,990
| +5% | +$94.1K |
2013 Q4
7 quarters
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, Geneva Advisors held 765 positions worth $4.96B, down 11% from $5.6B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geneva Advisors withdrew a net $193M in Q3 2015, closing 98 positions and reducing 270 holdings. Its most notable exit was Potash Corp Of Saskatchewan, an estimated $21.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Geneva Advisors opened a new position in Alphabet (Google) Class A worth $15.8M.
- Geneva Advisors's largest Q3 2015 buy was Alphabet (Google) Class A: 496,420 shares worth $15.8M.
- Geneva Advisors added most to Manhattan Associates in Q3 2015, an estimated $33.6M increase.
- Geneva Advisors's biggest Q3 2015 reduction was Biogen, cutting an estimated $49.9M.
- Geneva Advisors fully exited Potash Corp Of Saskatchewan in Q3 2015, selling an estimated $21.6M.
- Geneva Advisors's ten largest holdings make up 23% of its $4.96B portfolio in Q3 2015.
- Geneva Advisors opened 46 new positions and closed 98 in Q3 2015.
- Geneva Advisors's portfolio value fell 11% quarter-over-quarter to $4.96B.
Based on Geneva Advisors's 13F filing for Q3 2015, filed 3 Nov 2015.